Cargando…
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
Along with rising numbers of patients with metabolic syndrome, the prevalence of nonalcoholic fatty liver disease (NAFLD) has increased in proportion with the obesity epidemic. While there are no established treatments for NAFLD, current research is targeting new molecular mechanisms that underlie N...
Autores principales: | Huang, Yue Ye, Gusdon, Aaron M, Qu, Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827997/ https://www.ncbi.nlm.nih.gov/pubmed/24209497 http://dx.doi.org/10.1186/1476-511X-12-171 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics from a Mitochondria-Centric Perspective
por: Gusdon, Aaron M., et al.
Publicado: (2014) -
Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
por: Gusdon, Aaron M., et al.
Publicado: (2020) -
Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
por: Durazzo, Marilena, et al.
Publicado: (2012) -
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
por: Marchisello, Simona, et al.
Publicado: (2019) -
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
por: Dai, Xianmin, et al.
Publicado: (2021)